Transcription of The Transition to End-of-Life Care in End-Stage Liver Disease
{{id}} {{{paragraph}}}
Example: tourism industry
The Transition to End-of-Life Care in End-Stage Liver Disease
The Transition to End-of-Life Care inEnd-Stage Liver DiseasePaula Cox-North, MN, NP-C Ardith Doorenbos, PhD, RN Sarah E. Shannon, PhD, RN John Scott, MD, MSc Jared Randall Curtis, MD, MPHIn the United States, End-Stage Liver Disease (ESLD) is the12th leading cause of death and the 7th leading causeof death in people between the ages of 25 and 64 of ESLD such as ascites, varicealhemorrhage, hepatic encephalopathy, and renal impairmentprimarily account for these deaths. Patients with ESLD require increasingly complex medical support and manifesta spectrum of complications and symptoms that havesignificant impact on both survival and quality of the possibility of Liver transplantation,patients with ESLD are more likely to receive aggressivecare despite constant declining poor health.
disease, end of life, palliative care C irrhosis is a final common endpoint in patients with chronic progressive liver disease from a vari-ety of etiologies. Patients who have abnormalities of liver synthetic and excretory function and who develop ascites, variceal hemorrhage, hepatic encephalopathy, or
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: